News & Events
CPRIT makes childhood cancer a priority with 12% of its portfolio going to childhood cancer research — proportionately 3 times more than the national commitment. Ewing’s Sarcoma is a rare and devastating bone and soft-tissue cancer that mostly afflicts children and young adults for which no approved targeted therapies are currently available.
CPRIT is participating in BIO 2019 this week in Philadelphia with over 16,000 attendees representing the biotech and pharma industry from around the world. We will be educating them on funding opportunities for CPRIT’s Product Development Research program which is currently accepting applications for our Company Relocation Awards, Texas Company Awards, and Seed Awards.
AUSTIN — The Cancer Prevention and Research Institute of Texas (CPRIT) today awarded 10 new academic research grants totaling over $31 million to recruit eminent cancer researchers to Texas.
"Twelve years ago, Texas made history with an unprecedented initiative to take on cancer. Texas is clearly showing that the investment and focus have been worth it. We are making enormous progress in advancing the understanding of cancer science, accelerating potential cures and prevention strategies, and transforming the cancer landscape in Texas."